This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Summit At ChinaBio Partnering Forum
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026

Tony (Bizuo) Liu
Chairman and CEO at AbelZeta Pharma, Inc.
Speaker

Profile

Mr. Tony Bizuo LIU, joined AbelZeta in February 2013 as a director and a member of an audit committee. He was our chief financial officer and secretary between January 2014 and January 2016. Mr. Liu has been the chief executive officer of AbelZeta since February 2016 and appointed as a Director and the chairman of the Board since January 2021.

Prior to joining AbelZeta, Mr. Liu spent 19 years at Microsoft Corporation, a multinational technology conglomerate, where he served in a variety of finance leadership roles. He previously held senior positions at Alibaba Group Holding Limited, a multinational technology company, where he was primarily responsible for financial matters, investments and strategies.

Mr. Liu obtained his bachelor’s degree in physics from Soochow University in Jiangsu in July 1986. He has been certified by the Washington State Board of Accountancy as a certified public accountant in the State of Washington in the United States since 1992.

Agenda Sessions

  • Keynote Panel Discussion: Big Pharma’s Cell and Gene Therapies Wish List: Investment Priorities and Emerging Opportunities for Chinese Biotechs

    08:40